The VPS63 Antibody (Product Code: CSB-PA515555XA01SVG) is a polyclonal antibody raised against the VPS63 protein encoded by the VPS63 gene (UniProt ID: O13549) in Saccharomyces cerevisiae strain ATCC 204508/S288c . VPS63 is a vacuolar protein sorting (VPS) factor involved in intracellular trafficking and endosomal-lysosomal system regulation .
VPS63 is part of the VPS protein family, which regulates endosomal sorting, vesicle trafficking, and vacuolar biogenesis. Key findings include:
Role in Transcription Elongation: VPS factors, including those associated with PI(3)P kinase Vps34, enhance RNA polymerase II progression through coding sequences, suggesting a non-canonical role in transcription .
Genetic Interactions: vps63Δ mutants exhibit synthetic lethality with mutations in NuA4 histone acetyltransferase complex components, linking VPS63 to chromatin remodeling .
Cellular Localization: VPS proteins colocalize with nuclear pores at nucleus–vacuole junctions, potentially facilitating transcription-coupled trafficking .
While direct validation data for the VPS63 Antibody is limited in the provided sources, analogous workflows for VPS35 antibodies offer insights:
For VPS63, similar validation would involve confirming reactivity in vps63Δ yeast strains and colocalization with endosomal markers .
The VPS63 Antibody is critical for:
Mechanistic Studies: Investigating roles of VPS63 in transcription elongation and vesicle trafficking .
Phenotypic Analysis: Characterizing yeast mutants with defects in vacuolar protein sorting or autophagosome accumulation .
Localization Experiments: Mapping VPS63 to endosomal compartments or nuclear pores using immunofluorescence .
Although VPS63 itself is not directly linked to human diseases, studies on homologous proteins (e.g., VPS16, VPS35) highlight the broader significance of VPS pathways:
VPS63 (YLR261C) is a hypothetical open reading frame (ORF) in yeast that has been classified as "dubious" because it overlaps extensively with YPT6 but is translated in a different reading frame . The significance of VPS63 was highlighted when mass spectrometric analysis identified a peptide "(k)viyqmkgksqpkr" covering 11% of VPS63, providing the first experimental evidence that this protein is actually produced in yeast . The protein has a molecular weight of approximately 12.9 kDa, consistent with observations of a ~15 kDa band on SDS-PAGE . Understanding VPS63's potential role in vacuolar protein sorting pathways may provide insights into cellular trafficking mechanisms, which could have broader implications for protein transport research.
Based on current evidence and techniques used for similar proteins, researchers should consider:
Western Blotting: Most appropriate for initial detection and validation, as VPS63 has been identified on SDS-PAGE at approximately 15 kDa .
Immunoprecipitation: Valuable for isolating VPS63 and identifying potential interacting partners, particularly since VPS proteins often function in complexes .
Mass Spectrometry: While not an antibody-based technique itself, this should be used in combination with immunoprecipitation to confirm antibody specificity and validate true VPS63 detection .
Immunofluorescence: May be applicable for subcellular localization studies after thorough antibody validation.
Comprehensive antibody validation requires:
Positive Controls:
Cell extracts from systems known to express VPS63
Recombinant VPS63 protein (if available)
Negative Controls:
VPS63 knockout/knockdown samples
Pre-immune serum for polyclonal antibodies
Isotype-matched irrelevant antibodies
Specificity Controls:
Methodological Controls:
Multiple detection techniques to confirm findings
Varying antibody concentrations to establish optimal signal-to-noise ratios
Developing specific antibodies against VPS63 presents unique challenges due to its overlap with YPT6 . Advanced strategies include:
Epitope Selection:
Antibody Development Approaches:
Generate monoclonal antibodies for increased specificity
Employ recombinant antibody technologies (phage display, yeast display)
Develop nanobodies or single-chain variable fragments with enhanced specificity
Validation Strategies:
Implement CRISPR/Cas9-mediated knockout models as definitive specificity controls
Use orthogonal detection methods to confirm antibody specificity
Perform cross-adsorption against related proteins to remove cross-reactive antibodies
To investigate VPS63's potential role in protein sorting pathways:
Co-immunoprecipitation Studies:
Use VPS63 antibodies to pull down potential interacting partners
Perform reciprocal co-IPs with antibodies against known vacuolar sorting proteins
Validate interactions using multiple antibody clones targeting different epitopes
Proximity Labeling:
Combine with antibody-based purification for comprehensive interaction mapping
Use BioID or APEX2 fusion proteins to identify proximal proteins in living cells
Functional Assessment:
When faced with contradictory results:
Epitope Mapping:
Determine the specific epitopes recognized by each antibody
Assess whether discrepancies correlate with antibodies targeting different regions
Consider whether protein conformation affects epitope accessibility
Systematic Validation:
Compare antibody performance across multiple experimental platforms
Test antibodies using both native and denatured protein samples
Implement titration experiments to determine optimal concentrations
Independent Confirmation:
For optimal immunoprecipitation:
Sample Preparation:
Use gentle lysis buffers (1% NP-40 or CHAPS) to preserve protein-protein interactions
Include protease and phosphatase inhibitors to prevent degradation
Perform lysis at 4°C to minimize protein denaturation
Immunoprecipitation Strategy:
Pre-clear lysates with protein A/G beads to reduce non-specific binding
Determine optimal antibody concentration through titration experiments
Incubate with antibody overnight at 4°C with gentle rotation
Washing and Elution:
Optimize wash stringency to maintain specific interactions while removing background
Consider native elution with competing peptides if preserving complexes is important
Use appropriate controls including isotype-matched irrelevant antibodies
For quantitative assessment:
| Method | Key Considerations | Advantages | Limitations |
|---|---|---|---|
| Quantitative Western Blotting | - Use internal loading controls - Establish standard curves - Employ fluorescent secondary antibodies | - Good for relative quantification - Visual confirmation of size | - Limited dynamic range - Semi-quantitative |
| ELISA | - Develop sandwich ELISA with capture and detection antibodies - Include purified protein standards | - High sensitivity - Good for absolute quantification | - No size confirmation - Requires multiple antibodies |
| Flow Cytometry | - Optimize fixation and permeabilization - Use median fluorescence intensity | - Single-cell resolution - High throughput | - Complex protocol for intracellular proteins |
| Mass Spectrometry | - Use targeted approaches (PRM/MRM) - Include isotopically labeled standards | - Highest specificity - Can detect modifications | - Specialized equipment - Complex sample preparation |
To enhance detection sensitivity:
Signal Amplification Technologies:
Tyramide signal amplification for immunohistochemistry/immunofluorescence
Polymer-based detection systems with multiple secondary antibodies
Chemiluminescent substrates with enhanced sensitivity for Western blotting
Sample Enrichment:
Subcellular fractionation to concentrate compartments containing VPS63
Immunoprecipitation prior to detection by other methods
Optimize protein extraction methods for maximum yield
Advanced Imaging:
Use high-sensitivity cameras with back-illuminated sensors
Implement image accumulation techniques for low signals
Apply deconvolution algorithms to enhance signal-to-noise ratio
When analyzing variations across systems:
Biological Variation Assessment:
Technical Considerations:
Evaluate whether fixation and extraction methods affect detection efficiency
Determine if sample preparation protocols are optimized for each system
Assess whether detection antibodies have similar affinity across species
Data Interpretation Framework:
Establish baseline expression levels for each experimental system
Use multiple antibodies targeting different epitopes to confirm observations
Implement quantitative methods for objective comparison between systems
VPS63 antibodies could advance our understanding through:
Functional Characterization:
Disease Relevance:
Exploring whether VPS63 dysfunction contributes to diseases involving vacuolar sorting defects
Investigating potential connections to neurodegenerative disorders
Examining VPS63 expression in disease models
Evolutionary Biology:
Cutting-edge approaches include:
Spatial Transcriptomics and Proteomics:
Combining antibody detection with spatial mapping technologies
Correlating VPS63 localization with transcriptional profiles
Implementing multiplexed antibody detection systems
Single-Cell Proteomics:
Developing methods for single-cell VPS63 detection
Correlating VPS63 levels with cell-specific phenotypes
Implementing high-throughput single-cell antibody-based assays
Advanced Microscopy:
Applying super-resolution techniques for precise localization
Implementing light-sheet microscopy for 3D visualization
Using correlative light and electron microscopy for ultrastructural context
Antibody-based approaches to address the VPS63 classification:
Expression Verification:
Using antibodies to confirm endogenous expression across different conditions
Determining whether VPS63 is ubiquitously expressed or context-dependent
Quantifying expression levels relative to established proteins
Functional Validation:
Employing antibodies to identify interaction partners
Investigating whether VPS63 depletion affects vacuolar morphology
Examining if VPS63 colocalizes with other vacuolar sorting proteins
Relationship to YPT6: